TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19826203

Group type: EXPERIMENTAL
Intervention: Shape of the dose distribution (measured by lateral extent)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Shape of the dose distribution (measured by longitudinal extent)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dose-surface histogram (DSH)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Shape of the dose distribution
Number of subjects: 0
Study: 16399182

Group type: EXPERIMENTAL
Intervention: Stiffer implants (rigidity 1.8)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Regular implants (rigidity 1.0)
Number of subjects: 20
Study: 15565453

Group type: EXPERIMENTAL
Intervention: Administered dose of 0.001 Sv
Number of subjects: 0
Study: 11380543

Group type: EXPERIMENTAL
Intervention: Oil-in-water (o/w) cream applied 2x/day for 14 days in ICD study
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oil-in-water (o/w) cream applied 2x/day for 4 consecutive days in ACD study
Number of subjects: 0
Study: 8820892

Group type: EXPERIMENTAL
Intervention: Massage treatment
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (supine rest)
Number of subjects: 10
Study: 1526413

Group type: EXPERIMENTAL
Intervention: Propranolol for primary prevention of first bleeding in esophageal varices
Number of subjects: 109
Study: 3899947

Group type: EXPERIMENTAL
Intervention: 14-valent pneumococcal vaccine
Number of subjects: 405
Study: 31026125

Group type: EXPERIMENTAL
Intervention: Salt-related knowledge, attitudes, and practices (KAP) intervention; specific details on dosage and duration not available.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Advice to lower salt intake; specific details on dosage and duration not available.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Checking salt/sodium labels in food; specific details on dosage and duration not available.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adding extra salt to food at the table; specific details on dosage and duration not available.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reporting high amounts of salt consumption; specific details on dosage and duration not available.
Number of subjects: 0
Study: 29412368

Group type: EXPERIMENTAL
Intervention: Orofacial myofunctional therapy (OMT)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (normal occlusion)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Untreated group (UTG)
Number of subjects: 48
Study: 26946214

Group type: EXPERIMENTAL
Intervention: High axial force stent (WallFlex™)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low axial force stent (Niti‐S™)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison between W-group and N-group
Number of subjects: 0
Study: 23868613

Group type: COMPARATOR
Intervention: Mammography intervention (details not specified)
Number of subjects: 704
Study: 23070341

Group type: EXPERIMENTAL
Intervention: Goal-directed lactated Ringer's solution
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Goal-directed hydroxyethyl starch solution (6% hydroxyethyl starch solution 130/0.4)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Restrictive lactated Ringer's solution
Number of subjects: 60
Study: 20598806

Group type: EXPERIMENTAL
Intervention: Brief injunctive norms manipulation
Number of subjects: 265

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 265
Study: 18980664

Group type: EXPERIMENTAL
Intervention: Clinical pathway (intervention group)
Number of subjects: 476

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 476
Study: 15812751

Group type: EXPERIMENTAL
Intervention: Adriamycin chemotherapy (301 ± 52 mg/m²)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Adriamycin chemotherapy
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Baseline SOD levels
Number of subjects: 51
Study: 12454520

Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (alpha‐tocopherol and ascorbate)
Number of subjects: 595

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 595
Study: 10352369

Group type: EXPERIMENTAL
Intervention: Standardized acupuncture treatment
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo acupuncture
Number of subjects: 10
Study: 8547856

Group type: EXPERIMENTAL
Intervention: Caffeine (CAF) 10 mg/kg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Tryptophan (Trp) 1.2 g
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Combination of Caffeine and Tryptophan (CAF+Trp)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 8
Study: 1493533

Group type: EXPERIMENTAL
Intervention: Occlusive dressing technique using cream (without silicone oil)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Vaseline (control)
Number of subjects: 31
Study: 3991916

Group type: EXPERIMENTAL
Intervention: Cimetidine (1.6 g daily) for 24 h before and during the starvation period
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cimetidine and Placebo
Number of subjects: 20
Study: 30120003

Group type: EXPERIMENTAL
Intervention: Cliradex® eyelid cleanser
Number of subjects: 10

Group type: COMPARATOR
Intervention: 50% tea tree oil
Number of subjects: 10

Group type: COMPARATOR
Intervention: Oust™ Demodex® cleanser
Number of subjects: 10

Group type: COMPARATOR
Intervention: Blephadex™ eyelid foam
Number of subjects: 10

Group type: COMPARATOR
Intervention: TheraTears® SteriLid® eyelid cleanser
Number of subjects: 10

Group type: COMPARATOR
Intervention: Undiluted terpinen-4-ol
Number of subjects: 10

Group type: COMPARATOR
Intervention: Linalool
Number of subjects: 10

Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 10
Study: 29129441

Group type: EXPERIMENTAL
Intervention: Pembrolizumab 200 mg every 3 weeks (35 cycles)
Number of subjects: 305

Group type: COMPARATOR
Intervention: Chemotherapy (investigator-choice platinum-doublet chemotherapy, 4-6 cycles)
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Number of subjects: 305

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 305
Study: 23640810

Group type: EXPERIMENTAL
Intervention: Free anterolateral thigh perforator flap surgery
Number of subjects: 121

Group type: COMPARATOR
Intervention: Radial forearm free flap surgery
Number of subjects: 121
Study: 21233607

Group type: EXPERIMENTAL
Intervention: Fluorodeoxyglucose positron emission tomography (FDG‐PET)
Number of subjects: 100
Study: 19250084

Group type: EXPERIMENTAL
Intervention: Secondary prevention
Number of subjects: 360

Group type: COMPARATOR
Intervention: Primary prevention
Number of subjects: 360
Study: 17253155

Group type: EXPERIMENTAL
Intervention: Confirming feedback (information suggesting identification was correct)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Suspicion manipulation (reasons to entertain suspicion regarding the motives of the lineup administrator)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Confidence prophylactic effect (tested both immediately and after a one-week retention interval)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Suspicion manipulation
Number of subjects: 0
Study: 15476516

Group type: EXPERIMENTAL
Intervention: OROS-O (controlled-release oxybutynin)
Number of subjects: 105

Group type: COMPARATOR
Intervention: IR-O (immediate-release oxybutynin)
Number of subjects: 105
Study: 11411666

Group type: EXPERIMENTAL
Intervention: Prostate cancer patients with emotional support
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Prostate cancer patients with partners
Number of subjects: 431

Group type: COMPARATOR
Intervention: Randomly selected men
Number of subjects: 431
Study: 9148005

Group type: EXPERIMENTAL
Intervention: IMx CORE‐M assay
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: IMx CORE‐M index value
Number of subjects: 140
Study: 8375632

Group type: EXPERIMENTAL
Intervention: Intravesical administration of 1 mg oestriol
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 3781503

Group type: EXPERIMENTAL
Intervention: Experimental residential program providing 24-hour care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inpatient care (Control)
Number of subjects: 0
Study: 28464312

Group type: EXPERIMENTAL
Intervention: Retropubic tension-free vaginal tape (TVT)
Number of subjects: 569

Group type: COMPARATOR
Intervention: Transobturator tension-free vaginal tape (TVT-O)
Number of subjects: 569
Study: 27678290

Group type: EXPERIMENTAL
Intervention: Caffeine intake above median levels (mean intake = 261mg)
Number of subjects: 6467

Group type: COMPARATOR
Intervention: Caffeine intake below median levels (mean intake = 64mg)
Number of subjects: 6467
Study: 24762110

Group type: EXPERIMENTAL
Intervention: Calcium carbonate supplementation (1000 mg daily, 5 d/wk for 1 year)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 22467284

Group type: EXPERIMENTAL
Intervention: Phase-shifting pure tone treatment
Number of subjects: 22

Group type: COMPARATOR
Intervention: Pure tone treatment without phase shifting
Number of subjects: 22
Study: 20663131

Group type: EXPERIMENTAL
Intervention: Arctic Front(R) catheter
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: HD Mesh Ablator(R) catheter
Number of subjects: 108

Group type: COMPARATOR
Intervention: Brain MRI, neuro(psycho)logical tests, and reveal recorder for AF detection
Number of subjects: 108
Study: 18709309

Group type: EXPERIMENTAL
Intervention: Targeted broadband UVB phototherapy
Number of subjects: 10

Group type: COMPARATOR
Intervention: Targeted NB-UVB phototherapy
Number of subjects: 10
Study: 16124432

Group type: EXPERIMENTAL
Intervention: Ivermectin 0.2 mg/kg for 2 days
Number of subjects: 29

Group type: COMPARATOR
Intervention: Albendazole 400 mg twice daily for 21 days
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Ivermectin
Number of subjects: 29

Group type: COMPARATOR
Intervention: Albendazole
Number of subjects: 29
Study: 12610803

Group type: EXPERIMENTAL
Intervention: Intermittent cyclical etidronate therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Antirheumatic therapy alone (control)
Number of subjects: 40
Study: 10501887

Group type: EXPERIMENTAL
Intervention: Hyoscine-N-butylbromide (HB) 20 mg intraarterially
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no drug)
Number of subjects: 36
Study: 8943590

Group type: EXPERIMENTAL
Intervention: bupivacaine 0.125% with fentanyl 10 micrograms.ml‐1
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: bupivacaine 0.125% with diamorphine 125 micrograms.ml‐1
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: pethidine 2.5 mg.ml‐1
Number of subjects: 60
Study: 1683277

Group type: EXPERIMENTAL
Intervention: Dexetimide
Number of subjects: 261

Group type: COMPARATOR
Intervention: Artane
Number of subjects: 261
Study: 7034583

Group type: EXPERIMENTAL
Intervention: Epidural buprenorphine (0.15 mg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Epidural morphine (5 mg)
Number of subjects: 50
Study: 30630778

Group type: EXPERIMENTAL
Intervention: Delamanid (100 mg twice daily for 2 months followed by 200 mg once daily for 4 months)
Number of subjects: 511

Group type: COMPARATOR
Intervention: Placebo (same regimen as delamanid)
Number of subjects: 511

Group type: EXPERIMENTAL
Intervention: Delamanid
Number of subjects: 511

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 511
Study: 27170671

Group type: EXPERIMENTAL
Intervention: tDCS (anodal electrode on the rIFC, cathodal on the neck)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Sham (placebo) tDCS
Number of subjects: 31
Study: 25445201

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (500mg bid)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Clindamycin (150mg qid)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 24179298

Group type: EXPERIMENTAL
Intervention: Motivational enhancement therapy (MET)
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Education (ED)
Number of subjects: 227

Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 227
Study: 21852264

Group type: EXPERIMENTAL
Intervention: Flexible sigmoidoscopy screening
Number of subjects: 34136

Group type: COMPARATOR
Intervention: Control group (no further contact)
Number of subjects: 34136
Study: 19745649

Group type: EXPERIMENTAL
Intervention: Atomoxetine (80 mg/d)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 17326089

Group type: EXPERIMENTAL
Intervention: R2* imaging at 3T
Number of subjects: 34

Group type: COMPARATOR
Intervention: R2* imaging at 1.5T
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Combined R2* data from patients and control subjects
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: R2* imaging at 3T vs 1.5T in the liver
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: R2* imaging at 3T vs 1.5T in the heart
Number of subjects: 34
Study: 15029544

Group type: EXPERIMENTAL
Intervention: Patient-controlled analgesia with morphine (PCA)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Psoas compartment block (PCB)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Femoral nerve block (FNB)
Number of subjects: 45

Group type: COMPARATOR
Intervention: All groups (PCA, FNB, PCB)
Number of subjects: 45
Study: 11125723

Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Self-Monitoring Control (SMC)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy Deferred (CBT-DEF)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: CBT
Number of subjects: 139
Study: 9639078

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 4

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study: 8079104

Group type: EXPERIMENTAL
Intervention: 20 mg omeprazole daily at 0800 h (group A)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 20 mg omeprazole every other day (group B)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Both groups (A and B)
Number of subjects: 20
Study: 2788085

Group type: EXPERIMENTAL
Intervention: Supervised bicycle training programme three times a week for 12 weeks starting 6 weeks after surgery
Number of subjects: 37

Group type: COMPARATOR
Intervention: Non-training group
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Training group
Number of subjects: 37
Study: 178243

Group type: EXPERIMENTAL
Intervention: 2 mg glucagon intramuscularly
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 31904670

Group type: EXPERIMENTAL
Intervention: Short-term psychoeducational group intervention
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control individual psychoeducational schedule
Number of subjects: 80
Study: 30244348

Group type: COMPARATOR
Intervention: Yam peel meal (YPM) at 0% (T1)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Yam peel meal (YPM) at 50% (T2)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Yam peel meal (YPM) at 75% (T3)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Yam peel meal (YPM) at 100% (T4)
Number of subjects: 16
Study: 28394171

Group type: EXPERIMENTAL
Intervention: Mindful emotion awareness training
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cognitive reappraisal
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Combined interventions (mindful emotion awareness training and cognitive reappraisal)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Mindful emotion awareness training and cognitive reappraisal
Number of subjects: 10
Study: 25985045

Group type: EXPERIMENTAL
Intervention: Psychoanalytic psychotherapy (PPT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT)
Number of subjects: 0
Study: 23691822

Group type: EXPERIMENTAL
Intervention: Time constraint present
Number of subjects: 88

Group type: COMPARATOR
Intervention: No time constraint
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Multiple similarly named nontargets present
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Tall Man lettering
Number of subjects: 88
Study: 20966820

Group type: EXPERIMENTAL
Intervention: Surgical deactivation of migraine headache trigger sites
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Botulinum toxin injections to confirm trigger sites followed by surgical deactivation
Number of subjects: 125

Group type: COMPARATOR
Intervention: Saline injections (control)
Number of subjects: 125
Study: 18318728

Group type: EXPERIMENTAL
Intervention: Sequential delivery of 595-nm PDL and 1,064-nm Nd:YAG lasers
Number of subjects: 20

Group type: COMPARATOR
Intervention: 595-nm PDL laser alone
Number of subjects: 20

Group type: COMPARATOR
Intervention: 1,064-nm Nd:YAG laser alone
Number of subjects: 20
Study: 17078221

Group type: EXPERIMENTAL
Intervention: Mexicor
Number of subjects: 20
Study: 14604019

Group type: EXPERIMENTAL
Intervention: 0.65 g/kg dose of alcohol
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 10994825

Group type: EXPERIMENTAL
Intervention: Prophylactic cefazolin
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Vancomycin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Historical controls (not specified as a separate group)
Number of subjects: 60
Study: 8797620

Group type: EXPERIMENTAL
Intervention: Milrinone (50-micrograms/kg loading dose, followed by 0.25 microgram/kg/min continuous infusion)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Milrinone (50-micrograms/kg loading dose, followed by 0.5 microgram/kg/min continuous infusion)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Milrinone (50-micrograms/kg loading dose, followed by 0.75 microgram/kg/min continuous infusion)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study: 1626173

Group type: EXPERIMENTAL
Intervention: RU486 (600 mg) followed by Nalador (intravenous sulprostone)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Nalador only
Number of subjects: 73
Study: 6385894

Group type: EXPERIMENTAL
Intervention: Chloride titrator strip
Number of subjects: 32

Group type: COMPARATOR
Intervention: No use of chloride titrator strip (control)
Number of subjects: 32
Study: 30674987

Group type: EXPERIMENTAL
Intervention: Anodal stimulation of the right dorsolateral prefrontal cortex (dlPFC)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sham stimulation of the right dorsolateral prefrontal cortex (dlPFC)
Number of subjects: 100
Study: 28215130

Group type: EXPERIMENTAL
Intervention: Intravenous GLP-1 (1.2 pmol/kg/min)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 12
Study: 25730614

Group type: EXPERIMENTAL
Intervention: Real stimulation (rTMS)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 18
Study: 24357810

Group type: EXPERIMENTAL
Intervention: sifalimumab for 6 months
Number of subjects: 48

Group type: COMPARATOR
Intervention: placebo for 3 months
Number of subjects: 48
Study: 21653628

Group type: EXPERIMENTAL
Intervention: JOBS program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Voucher intervention
Number of subjects: 0
Study: 19122353

Group type: EXPERIMENTAL
Intervention: Exercise advice and prescription, dietary instructions
Number of subjects: 217

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 217
Study: 17413096

Group type: EXPERIMENTAL
Intervention: 1 meal/d
Number of subjects: 0

Group type: COMPARATOR
Intervention: 3 meals/d
Number of subjects: 0
Study: 15480049

Group type: EXPERIMENTAL
Intervention: CT scans of patients with MPO-ANCA
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: CT findings in patients with MPO-ANCA
Number of subjects: 62
Study: 11843382

Group type: EXPERIMENTAL
Intervention: Depot medroxyprogesterone acetate
Number of subjects: 1529

Group type: EXPERIMENTAL
Intervention: Levonorgestrel implants
Number of subjects: 1529

Group type: EXPERIMENTAL
Intervention: Progestogen-only oral contraceptives and progesterone vaginal ring
Number of subjects: 1529
Study: 9760010

Group type: EXPERIMENTAL
Intervention: Lubeluzole 2.5 mg, 5 mg, and 10 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Lubeluzole 15 mg, 20 mg, and 25 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 7930388

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) stimulation with arginine (0.5 g/kg bw) and recombinant GH (4 IU im) in Group 2 (normal IGF-I range)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) stimulation with arginine (0.5 g/kg bw) and recombinant GH (4 IU im) in Group 1 (abnormally low IGF-I concentration)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Arginine-stimulated GH peak values
Number of subjects: 39
Study: 3062957

Group type: COMPARATOR
Intervention: SSI 70
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Activitrax
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Nova MR
Number of subjects: 7
Study: 31936519

Group type: EXPERIMENTAL
Intervention: Chinese propolis paste as an intracanal medicament
Number of subjects: 80

Group type: COMPARATOR
Intervention: Calcium hydroxide (control)
Number of subjects: 80
Study: 29372626

Group type: EXPERIMENTAL
Intervention: Capecitabine/cisplatin (XP)
Number of subjects: 126

Group type: COMPARATOR
Intervention: 5-fluorouracil/cisplatin (FP)
Number of subjects: 126
Study: 26682955

Group type: EXPERIMENTAL
Intervention: ST2‐R2 score strata (score 9-11)
Number of subjects: 569

Group type: EXPERIMENTAL
Intervention: ST2‐R2 score strata (score 12-14)
Number of subjects: 569

Group type: EXPERIMENTAL
Intervention: ST2‐R2 score strata (score 15-17)
Number of subjects: 569

Group type: EXPERIMENTAL
Intervention: ST2‐R2 score
Number of subjects: 569
Study: 25428209

Group type: EXPERIMENTAL
Intervention: Management of vascular risk factors (physician-managed with biannual monitoring)
Number of subjects: 2210
Study: 23439168

Group type: EXPERIMENTAL
Intervention: Stepwise self-titration of oral glucose-lowering medication with self-monitoring and remote nurse monitoring
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Intervention group patients changing their oral glucose-lowering medication
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group patients changing their oral glucose-lowering medication
Number of subjects: 14
Study: 20528837

Group type: EXPERIMENTAL
Intervention: 5 mg/kg thiamylal
Number of subjects: 50

Group type: COMPARATOR
Intervention: 1.5 mg/kg propofol
Number of subjects: 50
Study: 17562958

Group type: EXPERIMENTAL
Intervention: Intramyocardial injection of autologous CD34+ stem cells
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 24